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Abstract: Boron is a naturally occurring trace element found in organic and inorganic complexes. Boron-containing compounds are
required for living organisms for diverse metabolic functions, including nitrogen fixation in microorganisms, cell wall stability in plants,
and bone and carbohydrate metabolism in animals. The number of studies about the effect of boron in biological model systems is very
limited; so far, there has been no study on the correlation between boron and amyloid-beta toxicity. Here, we investigated the possible
effects of 2 boron-containing compounds—sodium borate decahydrate and boric acid—against amyloid-beta toxicity. In our in vitro
amyloid-beta toxicity model, we showed that these 2 compounds increase the survival of the SH-SY5Y cells. Furthermore, boron in
these 2 forms increases the expression of Sirt1, which has protective functions against cellular stress. The compounds also change the
expressions of GSK-3α/β; by doing so, boron may contribute to the stimulation of intracellular prosurvival pathways. This is the first
experimental study indicating the prosurvival effect of boron in an amyloid-beta toxicity model.
Key words: Boron, neuronal survival, amyloid-beta, Sirt1, GSK-3α/β

1. Introduction
Boron is a naturally found trace element, according
to the World Health Organization (1996). Boron has
different isotopes and is not present in elemental form
in nature (Howe, 1998). It usually forms organoboron
complexes with oxygen and sodium. These organoboron
complexes are biologically important for living organisms.
In microorganisms, boron is required in many different
metabolic functions as diverse as quorum sensing,
nitrogen fixation, and antibiotic activity. In plants, it plays
an essential role in cell wall stability and leaf expansion;
its deficiency leads to dysfunction in expanding plant
organs and cell adhesion due to the altered polymerization
of the cytoskeleton and plasma membrane permeability.
In the animal kingdom, inorganic borate compounds are
transformed biologically and absorbed through mucosal
surfaces; approximately 90% of the boron compounds
given to animals is excreted in the form of boric acid. Recent
studies have shown that boron has important functions
in bone and carbohydrate metabolism, immunity, and
the endocrinal system of mammals, including human

beings. It is known that boron in the form of boric acid
is found in the tissues and body fluids of humans and
its deficiency causes a reduction in motor and cognitive
abilities (Nielsen, 1997; Penland, 1998; Sutherland et al.,
1998). In energy metabolism, there are at least 26 different
enzymes whose activities are affected by boron, and boron
containing compounds inhibit nicotinamide adenine
dinucleotide (NAD+) (Strittmatter, 1964; Deitrich, 1967;
Hunt et al., 1988; Aysan et al., 2011). It is well known that
NAD+ and NADP+ are the 2 ribose-containing molecules
with several functions in cellular energy metabolism;
boron has a strong affinity to these cofactors (Hunt,
2012). Considering that oxidative damage is a molecular
pathology in many different disorders, the role of boron
in the energy metabolism of the cell gains additional
importance.
Alzheimer’s disease (AD) is the most common
progressive neurodegenerative disease worldwide
(Blennow et al., 2006; Selkoe and Hardy, 2016). The
two neuropathological hallmarks of the disease are
intracytoplasmic protein inclusions, called neurofibrillary
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tangles (NFTs), and extracellular senile plaques,
composed mainly of amyloid-beta (Aβ) protein fragments
(Bennett et al., 2004; Götz et al., 2010). NFTs contain a
hyperphosphorylated form of microtubule-associated
protein tau in the form of paired helical filaments
(PHFs), and these tau aggregates generate toxicity and
drive the neuron to apoptosis (Götz et al., 2010). During
the degenerative process of AD, the tau aggregates
progressively accumulate in the soma of diseased neurons,
dystrophic neurites, and neuropil threads; this NFT
deposition leads to loss of synaptic function and neuronal
death (Khan and Bloom, 2016).
The other neuropathological feature of AD is
extracellular amyloid-beta (Aβ) plaques. Aβ is primarily
found in senile plaques and is generated by the sequential
proteolytic cleavage of amyloid precursor protein (APP)
through the action of secretases (Shankar et al., 2008;
Selkoe and Hardy, 2016). Generated Aβ fragments (39–42
amino acids in length) are secreted. Normally, this APP
processing is kept in a steady state, but disruption of the
metabolic balance of Aβ processing causes the formation
of toxic aggregates, which are linked to AD pathogenesis.
Recent literature also proves that extracellular Aβ
aggregates trigger the intracellular deposition of tau and
contribute to the formation of NFTs (Sadigh-Eteghad et
al., 2015).
As boron and its compounds have effects on cellular
energy metabolism, they could also have effects on
neurodegeneration, in which oxidative stress and related
pathologies have major importance.
Here we aim to investigate the possible effects of 2
boron-containing compounds in an in vitro amyloidbeta toxicity model. It is also widely known that sirtuin
families of proteins play critical roles in the survival of cells
under different stress conditions, and one of the family
members is Sirt1, which is an NAD+-dependent histone
deacetylase. Boron-containing compounds have effects
on NAD+ metabolism; hence, Sirt1, having antisenescence
and prosurvival effects, has been selected for this study
(Gizem and Leonard, 2010, Aysan et al., 2011). Among
the intracellular prosurvival pathways, Akt/GSK3-α/β is
a central pathway; these 2 proteins were chosen in our
experimental setting in order to elucidate the possible
roles of 2 boron-containing compounds in cell survival.
2. Materials and methods
2.1. Establishing in vitro Aβ1–42 toxicity model
SH-SY5Y human neuroblastoma cell line was purchased
(ATCC, USA) and they were cultured with Dulbecco’s
Modified Eagles Medium (DMEM) containing 10% (v/v)
heat-inactivated fetal bovine serum (Gibco, Gaithersburg,
MD, USA) and 100U penicillin–streptomycin (Gibco).

Cells were seeded in a 96-well plate at a density of
10,000cells/well; after 24 h, 4 different Aβ1-42 (Abcam, Cat
No: 120301; Cambridge, UK) concentrations (1.25µM,
2.5 µM, 5 µM, and10 µM) were applied in order to find
the effective toxic dose. Aβ1–42 was dissolved in 1% (v/v)
NH4OH (Larson, 2016). Lactate dehydrogenase (LDH)
assay (Roche, Cat No: 11644793001; Mannheim, Germany)
was performed for cell viability measurements. Briefly, the
working solution of the LDH assay was prepared according
to the manufacturer’s instructions and was incubated
in complete darkness for 15 min at room temperature.
The medium in which our cells were cultured was put
into a new 96-well plate in exactly the same order as the
original plate. Next, 100 µL of LDH working solution was
added to each well containing the cell culture medium to
produce a final volume of 200 μL. At 492 nm, absorbance
values in each well were measured in a microplate reader
(Chromate Manager 4300, Awareness Technology, Palm
City, FL, USA).
2.2. Application of boron-containing compounds
Sodium borate decahydrate (SBD) (Sigma-Aldrich, Cat No:
S9640, St. Louis, MO, USA) and boric acid (BA) (SigmaAldrich, Cat No: B6768) were dissolved in complete cell
culture medium and filtered with 0.22-μm filters (99722,
TPP, Trasadingen, Switzerland). SH-SY5Y cells were
cultured in 96-well plates with 10,000 cells/well; after
overnight incubation, the boron-containing compounds
were added into the cells in 5, 10, 15, 20, 50, 100, and
200 μg/mL concentrations. After 72 h of incubation, the
toxicity of the compounds on these cells was assessed by
LDH analysis. With this analysis, the optimum nontoxic
doses of the 2 compounds were determined.
2.3. Immunocytochemistry
SH-SY5Y cells were seeded into Petri dishes at a density of
50,000 cells/dish. After 24 h, Aβ1–42 (10 µM) was applied
and cells were incubated for 48 h. Using primary Aβ1–42
antibody (Santa Cruz Biotechnology, Cat No: sc-28365,
Santa Cruz, CA, USA), amyloid-beta aggregates were
visualized fluorescently using laser confocal microscopy.
Cell nuclei were visualized with DAPI. Petri dishes in
which SH-SY5Y cells were cultured without Aβ1–42 were
used as negative controls. All microscopy experiments were
conducted at least twice with different Aβ preparations.
2.4. Western blotting
At the end of the incubations, cells were detached with
1XPBS (Phosphate buffered saline, Gibco). After pelleting
the cells by centrifugation at 3000 rpm for 10 min at +4
°C, lysis buffer (1M Tris-HCl, 5M NaCl, Triton-X-100, 0.5
M EDTA) containing a protease/phosphatase inhibitor
cocktail (Cell Signaling Technology, Cat No: 5872,
Danvers, MA, USA) was added to the cells. Samples
were centrifuged at 14,000 rpm for 15 min at +4 °C and
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supernatants were collected. Protein concentrations were
determined spectrophotometrically (Implen, München,
Germany).
Forty µg of each protein sample from cell lysates were
separated by 4%–12% NuPAGE electrophoresis system
and samples were transferred to polyvinylidene fluoride
membranes (PVDF) using an iBlot Dry Blotting System
(Invitrogen, Carlsbad, CA, USA). Membranes were
blocked in 5% nonfat milk in 50mM Tris-buffered saline
containing 0.1% Tween-20 for 1 h at room temperature,
then washed in Tris-buffered saline containing 0.1%
Tween-20. The membranes were treated with the following
primary antibodies overnight at +4 °C: phospho-Akt (Cell
Signaling Technology, Cat No: 4051), total Akt (Cell
Signaling Technology, Cat No: 2920), phospho-GSK3β
(Cell Signaling Technology, Cat No: 8566), total GSK3β
(Cell Signaling Technology, Cat No: 9832), phospho-Tau
(Cell Signaling Technology, Cat No: 12885) and Sirt1 (Cell
Signaling Technology, Cat No: 9475). Primary antibodies
were diluted to 1:1000 in Tris-buffered saline containing
0.1% Tween-20. On the second day, the membranes
were washed and further incubated in blocking solution
with peroxidase-conjugated–secondary antibody (Cell
Signaling, Cat No: 7074S) for 1 h at room temperature.
All blots were performed at least 3 times and revealed
using a ECL-Advanced Western Blotting Detection Kit
according to the manufacturer’s protocol (Amersham
BioSciences, Cat No: RPN2232, Little Chalfont, UK).
Proteins were visualized with a Bio-Rad ChemiDoc XRS
System (Bio-Rad Laboratories Inc., Philadelphia, PA, USA)
and analyzed densitometrically with ImageJ software.
2.5. Statistical analysis
Data were statistically evaluated with one-way ANOVA.
A P value of less than 0.05 was regarded as being
statistically significant. For statistical data comparisons,
a standard software package (SPSS 18 for Windows; SPSS
Inc., Chicago, IL, USA) was used. Data were statistically
analyzed by using repeated-measures analysis of variance
(ANOVA), followed by the Tukey post-hoc test. Values are
given as mean and standard deviation of the mean (SD).
3. Results
3.1. The cell viability assays
In order to determine the most effective toxic dose of Aβ
on the SH-SY5Y cells, 4 different concentrations of Aβ1–42
(1.25 µM, 2.5 µM, 5 µM, and10 µM) were tested by LDH
analysis. Cell viability data showed that the 10 µM Aβ1–42
dose was the most effective toxic dose for these cells (P <
0.05, Figure 1a). The possible toxic effects of the 2 boroncontaining compounds (sodium borate decahydrate: SBD,
and boric acid: BA) were also investigated by LDH analysis
for 5, 10, 15, 20, 50, and 200 µg/mL concentrations; the
highest nontoxic concentrations of both compounds, i.e.
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200 µg/mL, were selected for our study (P < 0.01, Figure
1b and 1c).
After determining the most effective toxic dose of
Aβ1–42 and nontoxic doses of SBD and BA, the effects of
these 2 compounds on amyloid-beta toxicity were studied.
In order to assess their possible effects, SBD and BA were
applied 24 h before the Aβ1–42 treatment; they were also
applied 24 h after Aβ1–42 treatment. After 48 h of incubation,
cell viability was measured by LDH analysis and it was
shown that pre- and posttreatment of BA led to significant
increase in cell viability when compared with the Aβonly group (P < 0.01, Figure 1c). SBD posttreatment also
showed a significant rise in cell survival when compared
with the Aβ-only group (P < 0.01, Figure 1d).
3.2. Cellular imaging
After SH-SY5Y cells were cultured, 10 µM Aβ1–42 was
applied. At the end of 48 h of Aβ1–42 incubation, cells were
fixed with 4% paraformaldehyde. After permeabilization,
anti-Aβ antibody was used. Control samples were treated
with secondary antibody only. Laser confocal microscopy
revealed that amyloid-beta was internalized by the cells
(Figure 2).
3.3. Protein expression analyses
At the end of the incubation, cells were lysed as was
mentioned above and Sirt1, total, and phosphorylated
forms of GSK-3α/β and Akt were visualized and quantified.
Band intensities were normalized with corresponding
β-Actin bands (Figure 3a).
Although Aβ1–42 application increased Sirt1 expression
significantly, posttreatment of BA increased Sirt1
expression more strongly (P < 0.01, Figure3b). On the
other hand, posttreatment of SBD led to a statistically
significant decrease in Sirt1 expression (P < 0.01, Figure
3b). Other experimental groups did not show any
statistically significant changes in Sirt1 expression level.
A similar pattern was observed in total GSK-3α levels.
Aβ1–42 application and posttreatment of BA both led to
statistically significant elevations, but the amount of the
elevation was more prominent in the latter (P < 0.01,
Figure 3c). When phosphorylated GSK-3α (pGSK-3α)
level was assessed, its expression was found to be increased
in all experimental groups except for the SBD pretreatment
group (P < 0.01, Figure 3d).
When total GSK-3β levels were analyzed, there were
significant increases in the Aβ-only group and the BA
posttreatment group (P < 0.01, Figure 3e). When pGSK3β levels were studied, it was found that significant
elevations were observed in Aβ-only, SBD-only, and BA
posttreatment groups (P < 0.01, Figure 3f).
There were no statistically significant differences in any
experimental groups when Akt and pAkt were analyzed
(data not shown).
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Figure 1. LDH analyses of different concentrations of (a) Aβ1-42 (Elibol, 2019) , (b) Boric Acid (BA), (c) Sodium Borate Decahydrate
(SBD), and (d) effects of 200 µg/mL of BA and SBD on the viability of cells when 10 µM Aβ1-42 applied. *: P < 0.05; **: P < 0.01 against
the control group; ##: P < 0.01 against Aβ-only group.

4. Discussion
Boron is a naturally occurring mineral mostly found in
water-soluble forms. Boron-containing compounds are
ingested through a normal daily diet; because of their high
solubility and turn-over rate, they are excreted rapidly
(Howe, 1998). Although it has a high clearance rate,
boron has certain cellular and histological effects on living
organisms. It is already known that boron and boroncontaining compounds have regulatory effects on NAD+
and NADP+ metabolism; through these effects they may
have roles in cellular energy metabolism (Nielsen, 1997;
Howe, 1998).
Here, we have established an in vitro toxicity model
for investigating the possible effects of 2 boron-containing
compounds. In this model, Aβ1–42 was chosen to confer
toxicity, because it is clear from the relevant scientific
literature that amyloid-beta aggregates in the brain increase
in amount with aging, and with several neurodegenerative
disorders including Alzheimer’s disease. These aggregates
eventually lead to neuronal toxicity and death (Shankar et
al., 2008; Sadigh-Eteghad et al., 2015; Selkoe and Hardy,
2016).
In the present study, we have showed that both sodium
borate decahydrate (SBD) and boric acid (BA) have

viability-supporting effects in the amyloid-beta toxicity
model when they were used at 200 µg/mL doses. The cell
viability data of our study show that 10 µg/mL BA is more
toxic than the other concentrations, and 5 µg/mL BA is
less toxic than 10 and 15 µg/mL concentrations. When the
effects of SBD are examined, a different picture emerges.
For example, 5 µg/mL SBD seems to be the most toxic
dose, and while 15 µg/mL of SBD exhibits less toxicity than
10 and 20 µg/mL concentrations, toxicity starts to increase
again at 20 µg/mL, and then begins to drop. All of these
findings about the toxicity of BA and SBD for different
concentrations clearly indicate that the SH-SY5Y cells
respond to these compounds nonlinearly. Nonlinearity
to external insults or effects is one of the common
characteristics of all living systems, from unicellular
organisms to mammalians. This nonlinear response to BA
and SBD in the context of toxicity needs to be investigated
extensively, since the possible biological effects of boron
and/or boron-containing compounds have only been
studied in a limited fashion.
The implemented protein analyses might indicate the
possible mechanistic links between the prosurvival effects
of SBD and BA and intracellular signaling pathways.
First of all, amyloid-beta application by itself increases
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Figure 2. Immunocytochemical imaging. (a) shows the cell nuclei of the control sample
without Aβ, (b) exhibits the control sample without Aβ incubated with anti-Aβ antibody,
(c) shows the cell nuclei of the sample where 10 µM Aβ has been applied, (d) the sample
where 10 µM Aβ has been applied and incubated with anti-Aβ antibody. The green
fluorescence shows the amyloid beta aggregates inside the inside the SH-SY5Y cells
where 10 µM Aβ has been applied.

Sirt1 expression, and this would probably depend on the
function of Sirt1 in the cell. It has been revealed that Sirt1,
as a NAD+-dependent histone deacetylase, has a protective
role against oxidative stress (Rahman and Islam, 2011). It is
also known that Sirt1 expression increases in Alzheimer’s
disease and several other neurodegenerative disorders
in order to give protection against rising neuronal stress
(Kim et al., 2007; Michan and Sinclair, 2007; Gizem and
Leonard, 2010). Our data show that when Aβ1–42 is applied
to the SH-S5Y5 cells, Sirt1 expression is stimulated, and
more importantly, boric acid (BA) posttreatment after Aβ1–
application increases Sirt1 expression more than that of
42
the Aβ-only group (Figure 3a). This finding indicates that
BA posttreatment supports the protection against Aβ1–42
toxicity and the protective mechanism could be through
by rising Sirt1 expression.
The analysis of GSK-3α expression shows that total
GSK-3α expression increased in the Aβ-only group and
the posttreatment of BA group (Figure 3c). In addition to
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that, the phosphorylated form of GSK-3α also increased in
all experimental groups except for the SBD pretreatment
group (Figure 3d). It is clear from the other findings that
GSK-3α plays a role in amyloid-beta precursor protein
(APP) cleavage and processing.
We also studied the GSK-3α/β/Akt prosurvival pathway
to determine if it is involved in the survival-supporting
effects of boron-containing compounds. The data show
that the amyloid-beta application and BA posttreatment
groups both had increased total GSK-3β expression, and
its phosphorylated form also increased in these same
experimental groups (Figures 3e and 3f). Phosphorylated
GSK-3β expression was found to be increased in the SBDonly group as well (Figure 3f). These findings about GSK3β expression clearly reveal that intracellular prosurvival
pathways are activated; however, this activation of GSK3β could not be linked to the stimulation of Akt, because
neither the total Akt expression nor its phosphorylated
form were found to be increased (data not shown).
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Figure 3. Quantification of western blotting data and the image of the blot. (a) the expression of Sirt1, (b) the expression of total GSK-3β,
(c) the expression of p-GSK-3β, (d) the expression of total GSK-3α, (e) the expression of p-GSK-3α, (f) western blot membrane. SBD:
Sodium borate decahydrate; BA: Boric acid; *: P < 0.05, **: P < 0.01.

Taken together, all of these findings indicate that
SBD and BA have viability-increasing effects against
amyloid-beta toxicity, and these effects may depend on
the stimulation of GSK-3α/β expression. It may also be
necessary to analyze this effect further, because changes
seen in GSK-3α/β expression could not lead to Akt

activation. It is also important to note that Sirt1 might also
be involved in the protective effects of boron-containing
compounds, especially boric acid. To the best of our
knowledge, this is the first study investigating the effect of
boron on amyloid-beta toxicity in an in vitro cell culture
setting.
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